Michele Umbrello Selected Research

Michele Umbrello Research Topics

Disease

22	Critical Illness (Critically Ill) 02/2024 - 03/2010
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2023 - 11/2019
5	Sepsis (Septicemia) 04/2024 - 08/2017
4	Respiratory Insufficiency (Respiratory Failure) 02/2024 - 10/2021
4	COVID-19 05/2023 - 11/2021
3	Muscle Weakness 04/2024 - 05/2019
2	Septic Shock (Toxic Shock Syndrome) 04/2024 - 02/2024
2	Pain (Aches) 04/2024 - 01/2023
2	Delirium 01/2023 - 01/2019
2	Hypoxia (Hypoxemia) 10/2021 - 11/2013
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 11/2020
1	Wounds and Injuries (Trauma) 03/2024
1	Peroneal Neuropathies 03/2024
1	Multiple Organ Failure (MODS) 02/2024
1	Infections 02/2024
1	Constipation 12/2023
1	Opioid-Induced Constipation 12/2023
1	postintensive care syndrome 11/2023
1	Pneumonia (Pneumonitis) 05/2023
1	Brain Death (Brain Dead) 01/2023
1	Out-of-Hospital Cardiac Arrest 01/2023
1	Atrophic Muscular Disorders 03/2022
1	Barotrauma 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 10/2021
1	Thrombosis (Thrombus) 10/2021
1	Thrombocytopenia (Thrombopenia) 10/2021
1	Ventilator-Induced Lung Injury 11/2020
1	Hypovolemia 11/2020
1	Atrophy 09/2020
1	Coma (Comas) 01/2019
1	Pleural Effusion (Pleural Effusions) 03/2017
1	Hyponatremia 12/2016
1	Edema (Dropsy) 01/2014
1	Capillary Leak Syndrome 01/2014
1	Hypotension (Low Blood Pressure) 01/2014
1	Hyperglycemia 10/2008

Drug/Important Bio-Agent (IBA)

3	ProcalcitoninIBA 04/2024 - 05/2023
3	ElectrolytesIBA 01/2021 - 12/2016
3	MelatoninIBA 01/2019 - 03/2010
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 05/2019
2	Opioid Analgesics (Opioids)IBA 04/2024 - 12/2023
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 12/2023
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 10/2021
2	Indicators and Reagents (Reagents)IBA 05/2023 - 04/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2023
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2023
1	AlbuminsIBA 12/2023
1	Neuromuscular Blocking AgentsIBA 12/2023
1	Vasopressins (Vasopressin)IBA 12/2023
1	naldemedineIBA 12/2023
1	mu Opioid Receptors (mu Opioid Receptor)IBA 12/2023
1	C-Reactive ProteinIBA 05/2023
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Methylprednisolone FDA LinkGeneric 10/2021
1	ChAdOx1 nCoV-19IBA 10/2021
1	VaccinesIBA 10/2021
1	AutoantibodiesIBA 03/2021
1	Furosemide (Lasix)FDA LinkGeneric 01/2021
1	PotassiumIBA 11/2020
1	Sodium Chloride FDA LinkGeneric 11/2020
1	AcidsIBA 11/2020
1	Lipid NanoparticlesIBA 01/2019
1	SuspensionsIBA 01/2019
1	TabletsIBA 01/2019
1	CalciumIBA 08/2017
1	AntioxidantsIBA 04/2017
1	Tolvaptan FDA Link 12/2016
1	SodiumIBA 12/2016
1	MethemoglobinIBA 01/2014
1	SilverIBA 01/2014
1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2014
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 11/2013
1	Oxygen (Dioxygen)IBA 11/2013
1	PterinsIBA 11/2013
1	Heme (Haem)IBA 11/2013
1	EnzymesIBA 11/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2013
1	Hypnotics and Sedatives (Sedatives)IBA 04/2013
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 10/2008

Therapy/Procedure

8	Artificial Respiration (Mechanical Ventilation) 02/2024 - 04/2015
6	Critical Care (Surgical Intensive Care) 03/2024 - 11/2019
6	Nutritional Support (Artificial Feeding) 11/2023 - 11/2021
3	Mechanical Ventilators (Ventilator) 03/2022 - 11/2020
2	Therapeutics 02/2024 - 12/2016
2	Length of Stay 01/2022 - 01/2019
1	Physical Therapy Modalities (Physical Therapy Technique) 04/2024
1	Continuous Positive Airway Pressure 05/2023
1	Central Venous Catheters 03/2023
1	Extracorporeal Membrane Oxygenation 01/2023
1	Interactive Ventilatory Support 03/2022
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 10/2020
1	Music Therapy 08/2019
1	Conscious Sedation 10/2018
1	Intraperitoneal Injections 08/2017
1	Oral Administration 03/2010